Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Novak

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1972
Barbiturate interaction with phosphatidylcholineR F Novak, T J Swift
Biochemical and Biophysical Research Communications|December 22, 1999
The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expressionK J Woodcroft, R F Novak
Biochemical and Biophysical Research Communications|February 14, 1990
Induction of rat hepatic P450IIE1 (CYP 2E1) by pyridine: evidence for a role of protein synthesis in the absence of transcriptional activationS G Kim, R F Novak
Archives of Biochemistry and Biophysics|January 15, 1997
Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytesR C Zangar, R F Novak
Archives of Biochemistry and Biophysics|November 1, 1984
Spectroscopic evidence for anthracenedione antineoplastic agent self-association and complex formation with flavin nucleotidesE D Kharasch, R F Novak
Archives of Pharmacal Research|September 8, 2000
The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expressionR F Novak, K J Woodcroft
Cancer Research|September 1, 1990
Role of P450IIE1 in the metabolism of 3-hydroxypyridine, a constituent of tobacco smoke: redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridineS G Kim, R F Novak
Molecular Pharmacology|September 1, 1982
Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agentE D Kharasch, R F Novak
Archives of Biochemistry and Biophysics|November 1, 1981
The molecular basis for complexation of adriamycin with flavin mononucleotide and flavin adenine dinucleotideE D Kharasch, R F Novak
Archives of Biochemistry and Biophysics|July 15, 1983
Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclinesE D Kharasch, R F Novak
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1972
Barbiturate interaction with phosphatidylcholineR F Novak, T J Swift
Biochemical and Biophysical Research Communications|December 22, 1999
The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expressionK J Woodcroft, R F Novak
Biochemical and Biophysical Research Communications|February 14, 1990
Induction of rat hepatic P450IIE1 (CYP 2E1) by pyridine: evidence for a role of protein synthesis in the absence of transcriptional activationS G Kim, R F Novak
Archives of Biochemistry and Biophysics|January 15, 1997
Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytesR C Zangar, R F Novak
Archives of Biochemistry and Biophysics|November 1, 1984
Spectroscopic evidence for anthracenedione antineoplastic agent self-association and complex formation with flavin nucleotidesE D Kharasch, R F Novak
Archives of Pharmacal Research|September 8, 2000
The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expressionR F Novak, K J Woodcroft
Cancer Research|September 1, 1990
Role of P450IIE1 in the metabolism of 3-hydroxypyridine, a constituent of tobacco smoke: redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridineS G Kim, R F Novak
Molecular Pharmacology|September 1, 1982
Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agentE D Kharasch, R F Novak
Archives of Biochemistry and Biophysics|November 1, 1981
The molecular basis for complexation of adriamycin with flavin mononucleotide and flavin adenine dinucleotideE D Kharasch, R F Novak
Archives of Biochemistry and Biophysics|July 15, 1983
Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclinesE D Kharasch, R F Novak
Pageof 11